Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cells|May 20, 2020
Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian CancerManuel Abreu, Pablo Cabezas-Sainz, Lorena Alonso-Alconada, et al.Chempluschem|February 15, 2025
Triazole-Derived Ruthenium(II) Complexes as Novel Candidates for Cancer TherapyOscar A Lenis-Rojas, Catarina Roma-Rodrigues, Beatriz Carvalho, et al.Molecular Oncology|January 8, 2025
CRISPR targeting of FOXL2 c.402C>G mutation reduces malignant phenotype in granulosa tumor cells and identifies anti-tumoral compoundsSandra Amarilla-Quintana, Paloma Navarro, Iván Hernández, et al.Journal of Clinical Medicine|February 5, 2020
Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor CellsManuel Abreu, Pablo Cabezas-Sainz, Thais Pereira-Veiga, et al.Cell Death and Differentiation|July 22, 2022
Mitochondrial RNA methyltransferase TRMT61B is a new, potential biomarker and therapeutic target for highly aneuploid cancersAlberto Martín, Carolina Epifano, Borja Vilaplana-Marti, et al.Nature Aging|January 12, 2026
Senotoxins target senescence via lipid binding specificity, ion imbalance and lipidome remodelingJavier Moral-Sanz, Isabel Fernández-Carrasco, Valentina Ramponi, et al.Journal of Experimental & Clinical Cancer Research : CR|December 3, 2021
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drugEmilia Alors-Perez, Ricardo Blázquez-Encinas, Sonia Alcalá, et al.British Journal of Pharmacology|July 12, 2022
The structural conformation of the tachykinin domain drives the anti-tumoural activity of an octopus peptide in melanoma BRAF<sup>V600E</sup>Javier Moral-Sanz, Manuel A Fernandez-Rojo, Gonzalo Colmenarejo, et al.Journal of Experimental & Clinical Cancer Research : CR|January 27, 2024
Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategySonia Alcalá, Lara Villarino, Laura Ruiz-Cañas, et al.Journal of Experimental & Clinical Cancer Research : CR|April 29, 2025
Red blood cell-tumor cell interactions promote tumor cell progressionThais Pereira-Veiga, Celso Yáñez-Gómez, Aleksi Pekkarinen, et al.Pageof 2